TY - JOUR
T1 - Neddylated Cullin 3 is required for vascular endothelial-cadherin-mediated endothelial barrier function
AU - Sakaue, Tomohisa
AU - Fujisaki, Ayako
AU - Nakayama, Hironao
AU - Maekawa, Masashi
AU - Hiyoshi, Hiromi
AU - Kubota, Eiji
AU - Joh, Takashi
AU - Izutani, Hironori
AU - Higashiyama, Shigeki
N1 - Funding Information:
We thank Yusuke Fujioka (Department of Biochemistry and Molecular Genetics, Ehime University) for professional assistance. We gratefully appreciate Drs. Hirofumi Inoue, Shinji Fukuda, Daisuke Nanba, Hidetaka Ohnuki, and Hisayo Fukuda-Nishida of Ehime University for helpful discussions. This work was supported by Grants-in-Aid for Scientific Research (16H04698 to S.H. and 16K18421 to T.S.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.
Publisher Copyright:
© 2016 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Vascular endothelial (VE)-cadherin, a major endothelial adhesion molecule, regulates vascular permeability, and increased vascular permeability has been observed in several cancers. The aim of this study was to elucidate the role of the NEDD8-Cullin E3 ligase, in maintaining barrier permeability. To this end, we investigated the effects of the inhibition of Cullin E3 ligases, by using inhibitors and knockdown techniques in HUVECs. Furthermore, we analyzed the mRNA and protein levels of the ligases by quantitative RT-PCR and Western blotting, respectively. The results revealed that NEDD8-conjugated Cullin 3 is required for VE-cadherin-mediated endothelial barrier functions. Treatment of HUVECs with MLN4924, a chemical inhibitor of the NEDD8-activating enzyme, led to high vascular permeability due to impaired cell–cell contact. Similar results were obtained when HUVECs were treated with siRNA directed against Cullin 3, one of the target substrates of NEDD8. Immunocytochemical staining showed that both treatments equally depleted VE-cadherin protein localized at the cell–cell borders. However, quantitative RT-PCR showed that there was no significant difference in the VE-cadherin mRNA levels between the treatment and control groups. In addition, cycloheximide chase assay revealed that the half-life of VE-cadherin protein was dramatically reduced by Cullin 3 depletion. Together, these findings suggest that neddylated Cullin 3 plays a crucial role in endothelial cell barrier function by regulating VE-cadherin.
AB - Vascular endothelial (VE)-cadherin, a major endothelial adhesion molecule, regulates vascular permeability, and increased vascular permeability has been observed in several cancers. The aim of this study was to elucidate the role of the NEDD8-Cullin E3 ligase, in maintaining barrier permeability. To this end, we investigated the effects of the inhibition of Cullin E3 ligases, by using inhibitors and knockdown techniques in HUVECs. Furthermore, we analyzed the mRNA and protein levels of the ligases by quantitative RT-PCR and Western blotting, respectively. The results revealed that NEDD8-conjugated Cullin 3 is required for VE-cadherin-mediated endothelial barrier functions. Treatment of HUVECs with MLN4924, a chemical inhibitor of the NEDD8-activating enzyme, led to high vascular permeability due to impaired cell–cell contact. Similar results were obtained when HUVECs were treated with siRNA directed against Cullin 3, one of the target substrates of NEDD8. Immunocytochemical staining showed that both treatments equally depleted VE-cadherin protein localized at the cell–cell borders. However, quantitative RT-PCR showed that there was no significant difference in the VE-cadherin mRNA levels between the treatment and control groups. In addition, cycloheximide chase assay revealed that the half-life of VE-cadherin protein was dramatically reduced by Cullin 3 depletion. Together, these findings suggest that neddylated Cullin 3 plays a crucial role in endothelial cell barrier function by regulating VE-cadherin.
KW - Cullin 3
KW - MLN4924
KW - endothelial barrier function
KW - neddylation
KW - vascular endothelial-cadherin
UR - http://www.scopus.com/inward/record.url?scp=85014048932&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85014048932&partnerID=8YFLogxK
U2 - 10.1111/cas.13133
DO - 10.1111/cas.13133
M3 - Article
C2 - 27987332
AN - SCOPUS:85014048932
SN - 1347-9032
VL - 108
SP - 208
EP - 215
JO - Cancer science
JF - Cancer science
IS - 2
ER -